Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells - Concepedia

Concepedia

Publication | Closed Access

Synergistic activity of the new ABL-specific tyrosine kinase inhibitor STI571 and chemotherapeutic drugs on BCR-ABL-positive chronic myelogenous leukemia cells

173

Citations

32

References

2001

Year

Julian Topaly, WJ Zeller, Stefan Früehauf

Hematological MalignancySynergistic ActivityMedicineAnti-cancer AgentChemotherapeutic DrugsPharmacologyCell BiologyCancer ResearchTumor BiologyDrug DiscoveryMyeloid Neoplasia

References

	Year	Citations

Page 1